TickerFactsScreenerDevelopers

Serina Therapeutics, Inc. (SER) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $168.0K2018: $364.0K2019: $244.0K2020: $26.0K2021: $19.0K2022: $13.0K2023: $40.0K$40.0K
2017Cost of Revenue (USD)2023
Fiscal YearCost of RevenueChange YoY
2023$40.0K+207.7%
2022$13.0K-31.6%
2021$19.0K-26.9%
2020$26.0K-89.3%
2019$244.0K-33.0%
2018$364.0K+116.7%
2017$168.0K—